An NCIC-CTG phase I dose escalation pharmacokinetic study of the matrix metalloproteinase inhibitor BAY 12-9566 in combination with doxorubicin

Author: Hirte H.   Stewart D.   Goel R.   Chouinard E.   Huan S.   Stafford S.   Waterfield B.   Matthews S.   Lathia C.   Schwartz B.   Agarwal V.   Humphrey R.   Seymour and  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.23, Iss.5, 2005-10, pp. : 437-443

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content